Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03304080 |
| Title | Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Icahn School of Medicine at Mount Sinai |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Mount Sinai Beth Israel Comprehensive Cancer Center West | New York | New York | 10011 | United States | Details | |
| Perlmutter Cancer Center NYU Langone | New York | New York | 10016 | United States | Details | |
| Mount Sinai West | New York | New York | 10019 | United States | Details | |
| New York Presbyterian Columbia Irving Comprehensive Cancer Center | New York | New York | 10032 | United States | Details | |
| New York Presbyterian Weill Cornell Medical Center | New York | New York | 10065 | United States | Details |